VAERS Explorer
Back to explore

Report #2896705

Received May 15, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
Recovered
Unknown
Vaccinated
Onset
Jan 1, 2025
Days to onset
Hospital days

Vaccines (3)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (MODERNA))MODERNAUNKNo batch number
FLU3INFLUENZA (SEASONAL) (FLUZONE)SANOFI PASTEURUNKNo batch number
UNKVACCINE NOT SPECIFIED (NO BRAND NAME)UNKNOWN MANUFACTURERUNKNo batch number

Symptoms (5)

Abnormal loss of weightImmunisation reactionMuscle atrophyMyocardial infarctionWeight

Symptom narrative

Unintentional weight loss; Muscle wasting; Bad reaction; Heart attack; This spontaneous case, initially received on 06-May-2026, was reported by a non-health professional and concerns a patient of advanced age and unknown gender. Past medical history included Tachycardia. Vaccination history included Moderna COVID-19 vaccine (On an unknown date in Mar-2021 and Apr-2021). No concomitant medications were reported Administration of company suspect drug: On an unknown date, the patient received Fluad (TIV) for Product used for unknown indication, Dose regimen: 1 DF, Route of administration: Unknown, Anatomical location: Not reported, Lot number: No batch number available and and would be requested upon follow up. Non-company suspect drugs: On an unknown date, the patient received Fluzone (Influenza vaccine), Indication: Product used for unknown indication, Dose regimen: 1 DF, Route of administration: Unknown, Anatomical location: Not reported, Lot number: No batch number available. On an unknown date, the patient received Spikevax (Elasomeran), Indication: COVID-19 prophylaxis, Dose regimen: 1 DF, Route of administration: Unknown, Anatomical location: Not reported, Lot number: No batch number available. Adverse reactions/events and outcomes: On an unknown date in Jan-2025, the patient experienced Heart attack (Medically Significant, outcome: Unknown). On an unknown date, the patient experienced Unintentional weight loss (outcome: Unknown), Muscle wasting (outcome: Unknown), Bad reaction (outcome: Unknown). It was reported that the patient had been getting the Moderna COVID-19 vaccine yearly, since 2021 but he had unintentional weight loss where he was trying to figure out with doctor when exactly it started. The patient received Moderna vaccines in March 2021 and April 2021. It was reported that the patient received Fluad (Flu shot) only once due to a bad reaction (due to it being adjunct/increased for age making it stronger). Due to that, then decided to be gone back to receiving the High Zone moving forward. The patient received High Zone (Flu shot) yearly; usually, patient waited a month before receiving the said flu shot following Moderna COVID-19 vaccine administration. The reporter was asking about the connection between Moderna COVID-19 shots and unintentional weight loss, ingredients, reason behind changing in formulation, and when would the new formulation come out. One of reporter's friends suggested to look into the COVID-19 shots as per the said friend, it had so many issues. It was reported that the patient started weight gain several years ago, before the first Spikvax so was trying to see if there was any connection to the said product with unintentional weight loss probably going back 2–3 years ago but also said that it might not have anything to do with the COVID-19 shots. Additionally, the patient was confined due to the possibility of a minor heart attack at the beginning of January of 2025. He was then sent to rehab from had a heart attack. He had muscular dystrophy or muscle wasting, which was also described as a big issue, so had to work into it too. The reporter then confirmed that the patient did fine with 2025 after learning that there had been no changes to the inactive ingredients of the 2025–2026 Formula compared to previous Moderna COVID-19 vaccines. The patient did not experience any additional symptoms/events. No treatment information was provided. Lab test: On an unknown date, Weight was done, with result: Unintentional weight loss Fluad (TIV) action taken: Not Applicable Reporter's assessment: The reporter assessed the event Heart attack as serious (Medically Significant) and did not provide seriousness for other events. The causality assessment was not provided.; Reporter's Comments: Causality: Due to the spontaneous nature of the case, the events are considered related for reporting purposes. However, the information provided is insufficient to perform an in-depth analysis (event latency/temporality, relevant medical history, concomitant medications, investigation details, details of bad reaction etc.). Of note, non-company suspect drugs Fluzone and Spikevax could be considered as confounders. Furthermore, elderly age is a risk factor for Myocardial infarction, unintentional weight loss and Muscle atrophy.

Medical history

Medical History/Concurrent Conditions: Tachycardia

Lab data

Test Name: Weight; Result Unstructured Data: Unintentional weight loss